4European Pharmacopoeia Commission. European Pharmacopoeia 8.0, VolumeⅠ. Strasbourg: European Directorate for the Quality of Medicines of European Council, 2013: 242.
5Gao Q, Hua R M, Tang F, et al. Bull Environ Contam Toxicol, 2010, 84: 779.
6林建. [硕士学位论文]. 杭州: 浙江大学, 2010.
7National Committee for Clinical Laboratory Standards. Evaluation of Matrix Effects; Approved Guideline. NCCLS document EP14-A, 2001.
8Liu H M, Kong W J, Gong B. J Chromatogr B, 2015, 974: 65.
9Gilbert-López B, García-Reyes J F, Ortega-Barrales P, et al. Rapid Commun Mass Spectrom, 2007, 21: 2059.
